首页> 外国专利> USE OF DERMATAN SULFATE FOR PREVENTING AND CURING SENESCENCE OF BRAIN AND FUNCTION- DEFICIENT CONDITION OF CENTRAL NERVOUS SYSTEM

USE OF DERMATAN SULFATE FOR PREVENTING AND CURING SENESCENCE OF BRAIN AND FUNCTION- DEFICIENT CONDITION OF CENTRAL NERVOUS SYSTEM

机译:硫酸真皮的预防和治疗对大脑的敏感性和中枢神经系统功能缺损的状况

摘要

PURPOSE: To obtain a pharmaceutical composition containing dermatan sulfate or the combination of the dermatan with heparin as an active ingredient and useful for preventing and treating the aging of brains and the insufficient function states of central nervous systems. CONSTITUTION: This pharmaceutical composition contains natural dermatan sulfate having an average mol.wt. of 20,000-40,000 dalton or low mol.wt. dermatan sulfate having an average mol.wt. of 3,000-20,000 dalton or the combination of the dermatan sulfate with 0.5-10wt.% of heparin as an active ingredient. The composition is useful for treating central nervous system hypofunctions related to the biochemical modulation of glycosaminoglycan sulfate due to toxic dependency caused by the excessive use of a drug and for treating the ageing of brains in the forms of childish and senile dementias which are the syndromes of insufficient metabolisms.
机译:用途:获得包含硫酸皮肤素或皮肤素与肝素的组合作为活性成分并且可用于预防和治疗脑部衰老和中枢神经系统功能不足的药物组合物。组成:该药物组合物包含平均摩尔重量的天然硫酸皮肤素。 20,000-40,000道尔顿或低分子量具有平均分子量的硫酸皮肤素。剂量为3,000-20,000道尔顿,或硫酸皮肤素与0.5-10wt。%肝素作为活性成分的组合。该组合物可用于治疗由于过量使用药物引起的毒性依赖性而引起的与硫酸糖胺聚糖硫酸盐的生物化学调节有关的中枢神经系统功能减退,以及用于治疗幼年和老年性痴呆形式的脑衰老,所述幼年和老年性痴呆是糖尿病的综合征。新陈代谢不足。

著录项

  • 公开/公告号JPH04234819A

    专利类型

  • 公开/公告日1992-08-24

    原文格式PDF

  • 申请/专利权人 MEDIOLANUM FARMACEUT SRL;

    申请/专利号JP19910096100

  • 发明设计人 RINARUDO DERU BONO;JIYANNI FUETSURAARI;

    申请日1991-04-03

  • 分类号C08B37/08;A61Knull/null;A61K31/70;A61K31/715;A61P25/00;A61P25/28;C08B37/10;

  • 国家 JP

  • 入库时间 2022-08-22 05:44:32

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号